definiens: means : ] . meaning the technology claimed in the following Patents to which CAT has sole right, title and interest : ( a)Cell;"'free synthesis and isolation of novel genes and polypeptides PCTIUS90/05682, filed 2 October 1990 ; ( b ) Improvements to Ribosome Display, PCT / GBOl!01319 filed March 26, 200 ] ; 2 . meaning solely those Antibodies which bind to and catalyze the chemical transformation of a substrate and in which an Antibody binding region is involved in said catalysis ; 3 . meaning those certain research products for which CAT has granted certain exclusive rights to a Third Party under the Amersham License Agreement, as may then be in effect ; and 4 . meaning any Antibody mieroarray product for the purpose of simultaneously detecting and/or measuringi\ntigens whereby that product : ( a ) contains or comprises : ( i ) an iarray · of three ( 3 ) or more Antibodies of different Antigen specificity ( excluding Antibodies serving a purpose as controls ), or ( ii ) an array of one ( 1 ) or more Antibodies of the same Antigen 's ~ eifieity ; provided that such Antibody is used to detect andlor measure three ( 3 ) or more data points for the purpose of quantifying the Antigen ' ( excluding Antibodies serving a purpose as controls ), and ( b ) contains or comprises an array of Antibodies affixed to a supporting surface either before or after binding to Antigen, and ( c ) is in a format where the Antibodies are combined with one test sample of multiple Antigens, and ( d ) employs any type of micro flu idics - based screening system, and ( e ) may be used in vitro or in vivo ( as appropriate ), and ( f ) is not, by way of example, ( i ) any type ofimmunochemical ELISA orElA technology ; ( ii ) any type of RIA technology ; ( iii ) any type of immunochromatographic assay